The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...
In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...
Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...
Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.
Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of ...
University of Calgary researchers with the Calgary Stroke Program continue to advance the science to determine best ...
A 63-year-old resident of Vadarvasti in Karve Nagar, Pune, succumbed to complications arising from Guillain-Barré Syndrome ...
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
LOS ANGELES -- For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive ...
Intensive BP lowering after successful endovascular thrombectomy for acute anterior circulation ischemic stroke did not improve 90-day functional outcomes vs. standard BP control, a speaker ...
(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system-the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results